Mark McAlister, based in United Kingdom, is currently a Cofounder Fusiomica - de novo protein design at Fusiomica. Mark McAlister brings experience from previous roles at Stealth Biotech and AstraZeneca. Mark McAlister holds a 1993 - 1995 Postdoc in Structural Biology and Biochemistry @ University of Oxford. Mark McAlister has 1 emails on RocketReach.
Looking for a different Mark McAlister?
Find contact details for 700 million professionals.